$151 Million is the total value of EMORY UNIVERSITY's 46 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 30.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $32,999,000 | -5.7% | 117 | 0.0% | 21.90% | -12.4% | |
| JD | Buy | JD COM INCspon adr cl a | $15,486,000 | +207.2% | 397,578 | +219.4% | 10.28% | +185.5% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $3,555,000 | +56.0% | 89,951 | +1.7% | 2.36% | +45.1% |
| GHDX | Sell | GENOMIC HEALTH INC | $3,552,000 | +42.7% | 70,470 | -11.5% | 2.36% | +32.6% |
| HRTX | New | HERON THERAPEUTICS INC | $3,282,000 | – | 84,475 | +100.0% | 2.18% | – |
| SGEN | Sell | SEATTLE GENETICS INC | $3,103,000 | +23.3% | 46,734 | -2.8% | 2.06% | +14.6% |
| ZGNX | Buy | ZOGENIX INC | $3,083,000 | +21.2% | 69,746 | +9.8% | 2.05% | +12.7% |
| ABMD | New | ABIOMED INC | $2,890,000 | – | 7,065 | +100.0% | 1.92% | – |
| FOX | Buy | TWENTY FIRST CENTY FOX INCcl b | $2,858,000 | +37.3% | 58,010 | +1.4% | 1.90% | +27.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $2,844,000 | +13.8% | 30,190 | -2.1% | 1.89% | +5.8% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $2,844,000 | +9.5% | 182,043 | +5.4% | 1.89% | +1.8% |
| ECYT | New | ENDOCYTE INC | $2,833,000 | – | 205,295 | +100.0% | 1.88% | – |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $2,831,000 | +11.1% | 28,819 | -6.2% | 1.88% | +3.2% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $2,814,000 | -25.0% | 123,055 | -30.2% | 1.87% | -30.3% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $2,741,000 | +12.8% | 22,081 | +1.3% | 1.82% | +4.8% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $2,696,000 | -12.2% | 40,528 | -13.6% | 1.79% | -18.4% |
| INCY | Buy | INCYTE CORP | $2,669,000 | +5.2% | 39,831 | +30.8% | 1.77% | -2.2% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $2,598,000 | +35.3% | 67,925 | +41.8% | 1.72% | +25.7% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $2,586,000 | +1.9% | 26,256 | +23.2% | 1.72% | -5.4% |
| TGTX | New | TG THERAPEUTICS INC | $2,570,000 | – | 195,463 | +100.0% | 1.71% | – |
| IFRX | Sell | INFLARX NV | $2,501,000 | -4.5% | 77,554 | -14.6% | 1.66% | -11.2% |
| KKR | Buy | KKR & CO L P DEL | $2,474,000 | +27.9% | 99,559 | +4.4% | 1.64% | +18.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $2,455,000 | +22.1% | 54,317 | +30.5% | 1.63% | +13.5% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $2,426,000 | +5.3% | 83,163 | +7.5% | 1.61% | -2.1% |
| ADS | Buy | ALLIANCE DATA SYSTEMS CORP | $2,425,000 | +31.5% | 10,400 | +20.1% | 1.61% | +22.2% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $2,425,000 | -6.7% | 15,495 | -3.9% | 1.61% | -13.2% |
| AWI | Buy | ARMSTRONG WORLD INDS INC NEW | $2,343,000 | +21.5% | 37,069 | +8.3% | 1.56% | +12.9% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $2,248,000 | – | 175,597 | +100.0% | 1.49% | – |
| CBRE | Sell | CBRE GROUP INCcl a | $2,204,000 | -0.5% | 46,168 | -1.5% | 1.46% | -7.5% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $2,202,000 | -31.6% | 14,321 | -25.3% | 1.46% | -36.4% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $2,201,000 | +15.6% | 144,125 | +70.1% | 1.46% | +7.4% |
| CORI | Buy | CORIUM INTL INC | $2,200,000 | -8.9% | 274,651 | +30.4% | 1.46% | -15.4% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $2,200,000 | -6.6% | 179,568 | -27.1% | 1.46% | -13.2% |
| SLM | New | SLM CORP | $2,150,000 | – | 187,754 | +100.0% | 1.43% | – |
| KALA | Sell | KALA PHARMACEUTICALS INC | $2,120,000 | -24.5% | 154,391 | -12.9% | 1.41% | -29.8% |
| STX | Sell | SEAGATE TECHNOLOGY PLC | $2,118,000 | -12.2% | 37,505 | -9.0% | 1.41% | -18.4% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $2,101,000 | -28.8% | 33,101 | +2.9% | 1.40% | -33.8% |
| TRN | Buy | TRINITY INDS INC | $2,102,000 | +5.9% | 61,362 | +0.9% | 1.40% | -1.6% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $2,096,000 | -10.3% | 108,679 | +7.3% | 1.39% | -16.7% |
| C | New | CITIGROUP INC | $1,995,000 | – | 29,811 | +100.0% | 1.32% | – |
| MS | Buy | MORGAN STANLEY | $1,874,000 | -9.7% | 39,532 | +2.8% | 1.24% | -16.1% |
| SMLP | SUMMIT MIDSTREAM PARTNERS LP | $1,348,000 | +9.6% | 87,560 | 0.0% | 0.90% | +1.9% | |
| COCP | COCRYSTAL PHARMA INC | $560,000 | -38.5% | 152,916 | 0.0% | 0.37% | -42.8% | |
| AQXP | Buy | AQUINOX PHARMACEUTICALS INC | $554,000 | -78.0% | 209,207 | +16.8% | 0.37% | -79.6% |
| AMZN | AMAZON COM INC | $269,000 | +17.5% | 158 | 0.0% | 0.18% | +9.1% | |
| SPY | SPDR S&P 500 ETF TRtr unit | $237,000 | +3.5% | 872 | 0.0% | 0.16% | -4.3% | |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -28,172 | -100.0% | -1.39% | – |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -23,505 | -100.0% | -1.53% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -62,410 | -100.0% | -1.74% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -115,136 | -100.0% | -1.84% | – |
| ABLX | Exit | ABLYNX NVsponsored adr | $0 | – | -48,194 | -100.0% | -1.88% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -39,066 | -100.0% | -1.90% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -22,474 | -100.0% | -1.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
| 13F-HR | 2019-02-12 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.